PHILADELPHIA, May 22, 2017 /PRNewswire/ -- Aberdeen
Singapore Fund, Inc. (the "Fund") (NYSE: SGF), a closed-end
equity fund, announced today its performance data and portfolio
composition as of April 30, 2017.
The Fund's total returns for various periods through
April 30, 2017 are provided
below. (All figures are based on distributions reinvested at
the dividend reinvestment price and are stated net-of-fees):
|
Cumulative as of
04/30/17
|
Annualized as of
04/30/17
|
|
1 Month
|
3 Month
|
YTD
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
Since
Inception
|
NAV
|
1.2
|
7.6
|
17.3
|
14.2
|
-0.5
|
2.8
|
2.2
|
5.0
|
Market
Price
|
2.4
|
16.7
|
27.7
|
21.8
|
0.3
|
3.2
|
2.4
|
4.3
|
MSCI
Singapore
|
0.3
|
5.0
|
13.8
|
9.3
|
-1.7
|
1.6
|
3.0
|
6.1
|
On April 30, 2017, the Fund's net
assets amounted to US$90.7 million
and the Fund's NAV per share was US$12.22.
As of April 30, 2017, the
portfolio was invested as follows:
Portfolio
Composition
|
Percent of
Net Assets
|
Financials
|
28.9
|
Real
Estate
|
25.0
|
Industrials
|
23.3
|
Telecommunications
|
7.0
|
Information
Technology
|
4.2
|
Health
Care
|
3.8
|
Consumer
Discretionary
|
3.7
|
Consumer
Staples
|
1.9
|
Materials
|
0.3
|
Cash
|
1.9
|
The Fund's ten largest equity holdings as of April 30, 2017, representing 61.6% of net assets,
were:
Stock
|
Percent
of
Net
Assets
|
Oversea-Chinese
Banking Corporation
|
10.5
|
DBS Group
Holdings
|
8.3
|
City
Developments
|
7.4
|
Singapore
Telecom
|
7.0
|
United Overseas
Bank
|
6.6
|
Jardine
Matheson
|
6.0
|
Keppel
Corporation
|
4.5
|
Venture
Corporation
|
3.8
|
Raffles Medical
Group
|
3.8
|
Comfortdelgro Corp.
NPV
|
3.7
|
Important Information
Aberdeen Asset Management Inc.
has prepared this report based on information sources believed to
be accurate and reliable. However, the figures are unaudited
and neither the Fund, Aberdeen Asset Management Inc. (the
Administrator), Aberdeen Asset Management Asia Limited (the
Investment Manager), nor any other person guarantees their
accuracy. Investors should seek their own professional advice
and should consider the investment objectives, risks, charges and
expenses before acting on this information. The Investment Manager
and Administrator are each a wholly owned subsidiary of Aberdeen
Asset Management PLC. Aberdeen Asset Management PLC announced
on March 6, 2017 that it entered into
an agreement with Standard Life plc to carry out an all-share
merger, subject to regulatory and other approvals. More
information about the potential merger can be found on Aberdeen's
website at www.aberdeen-asset.com. Aberdeen is a U.S. registered
service mark of Aberdeen Asset Management PLC.
Closed-end funds are traded on the secondary market through one
of the stock exchanges. The Fund's investment return and principal
value will fluctuate so that an investor's shares may be worth more
or less than the original cost. Shares of closed-end funds may
trade above (a premium) or below (a discount) the net asset value
(NAV) of the fund's portfolio. There is no assurance that the Fund
will achieve its investment objective.
Total return figures with distributions reinvested at the
dividend reinvestment price are stated net-of-fees and represents
past performance. Past performance is not indicative of
future results, current performance may be higher or lower.
Holdings are subject to change and are provided for informational
purposes only and should not be deemed as a recommendation to buy
or sell the securities shown. Inception date July 31, 1990.
If you wish to receive this information
electronically, please contact:
InvestorRelations@aberdeen-asset.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/aberdeen-singapore-fund-inc-announces-performance-data-and-portfolio-composition-300461691.html
SOURCE Aberdeen Singapore Fund, Inc.